Skip to main content

News

Seropositivity Increases Risk of Rheumatoid Mortality

Three European registries analyzed their cohorts for outcomes that may be related to seropositivity for anticitrullinated protein antibodies (ACPA), rheumatoid factor (RF) and anticarbamylated protein (anti-CarP) antibodies.

Prescribing Rules

If you are responsible for the outcome and welfare of patients – you need prescribing rules.

If you are supervising others or responsible for the training of those learning rheumatology – you need prescribing rules.

Combination or Monotherapy Tocilizumab in Rheumatoid Arthritis

Several rheumatoid arthritis studies have shown that tocilizumab (TCZ) may be as effective as monotherapy when compared to combination therapy (methotrexate plu

Cochrane Reviews Low Back Pain and Exercise

A new Cochrane Review published today shows that targeting exercises to muscles that support and control the spine offers another strategy to reduce pain and disability caused by lower back pain.

Game-Changers 2015: Refining Treatment in Arthritis

Widening experience with JAK inhibition for rheumatoid arthritis (RA) and tapering medications among RA patients in remission, along with the success of secukinumab for psoriatic arthritis (PsA), were the most important advances in rheumatology in 2015, according to specialists responding toMedPa

The Global Prevalence of Spondyloarthritis

SpA is a common disease, but with large variation in reported prevalence estimates, partly explained by differences in demographical and methodological characteristics. 

Increasing Hospitalization Rates for Shingles in Lupus

An administrative claims study of lupus patients drawn from the United States National Inpatient Sample between 2000 to 2011, studied hospitalization rates related to bacteremia, pneumonia, opportunistic fungal infection, herpes zoster, cytomegalovirus, or pneumocystis pneumonia (P

New Scoring System Predicts 1 year survival in Hip Fracture Patients

A prospective study was conducted in Germany to establish predictors of 1 year survival after a hip fracture in elderly people.

Secukinumab Shows Efficacy in Two Ankylosing Spondylitis Trials

NEJM has published the results of two studies wherein IL-17 inhibition with secukinumab (SEC) was shown to be effective in patients with anklylosing spondylitis.

Increased Adverse Pregnancy Outcomes in Ankylosing Spondylitis

Although ankylosing spondylitis affects a predominantly male population, the ratio of men to women has declined from 9-10:1 in earlier studies to more recent estimates of 2-3:1 (F:M).

Famous Rheumatologist Quotes – Part II

Last month, many rheumatologists offered up their favorite quotes. Most of these were on medicine, medical skills, some pertained to rheumatology and others were axioms for life.

CDC Reports Increasing Narcotic Deaths

A recent Morbidity Mortality Weekly Report from the CDC reviewed the epidemic of drug overdose (poisoning) deaths in the USA.

×